Alteplase Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Alteplase Injection (injection) from Genentech, Inc with status To Be Discontinued. The shortage was first posted on 05/21/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Genentech, Inc
- Package NDC
- 50242-085-27
- Dosage Form
- Injection
- Presentation
- Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27)
- Initial Posting
- 05/21/2026
- Revised Date